T1	Participants 31 96	positron emission tomography-negative stage I/II Hodgkin lymphoma
T2	Participants 311 367	patients with clinical stage I/II Hodgkin lymphoma (HL).
T3	Participants 666 735	patients attaining a negative early PET scan after two cycles of ABVD
T4	Participants 867 947	Patients age 15 to 70 years with untreated clinical stage I/II HL were eligible.
T5	Participants 1279 1316	The analysis included 1,137 patients.
T6	Participants 1324 1342	favorable subgroup
T7	Participants 1446 1466	unfavorable subgroup
